Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.
Capital Gas ship becomes the second non-sanctioned LNG carrier in over a year to take Red Sea route The 148,174-cbm Salalah LNG (built 2005) delivered a shipment from Oman LNG to Turkey’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback